OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial

Esther Irene Schwarz (Zurich, Switzerland), Esther I. Schwarz, Michael Furian, Christian Schlatzer, John R. Stradling, Malcolm Kohler, Konrad E. Bloch

Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Session: Inflammation, biomarkers and hypoxia in sleep disordered breathing
Session type: Thematic Poster Session
Number: 2333
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Esther Irene Schwarz (Zurich, Switzerland), Esther I. Schwarz, Michael Furian, Christian Schlatzer, John R. Stradling, Malcolm Kohler, Konrad E. Bloch. OSA results in nocturnal cerebral hypoxia which is prevented by CPAP - Data from a randomised controlled trial. Eur Respir J 2015; 46: Suppl. 59, 2333

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



OSAS treatment with CPAP: Randomized crossover study comparing tolerance and efficacy with and without humidification
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


A randomized controlled trial of a novel sleep surface for treatment of positional sleep apnea
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016


The micro-RNA hsa-miR-502-3p is down-regulated in the plasma of obstructive sleep apnea patients after 2 weeks of continuous positive airway pressure therapy withdrawal: Data from a randomized controlled trial
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

A prospective, randomised, controlled trial of CPAP in adults with Down syndrome
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


A randomized controlled trial of auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ)
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016

Positional therapy as a treatment for central sleep apnoea: A prospective multicentre trial
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016

The effect of CPAP on blood pressure in patients with OSAS and resistant hypertension followed 1 year
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Impact of continuous positive airway pressure on liver injury induced by obstructive sleep apnea: Data from randomized controlled trials
Source: International Congress 2015 – A bout de souffle: hypoxia and sleep-disordered breathing
Year: 2015


Effect of continuous positive airway pressure on blood pressure and the metabolic profile of women with obstructive sleep apnoea. A randomized-controlled trial
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016



Response to statin therapy in obstructive sleep apnea (OSA): A randomized controlled trial
Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing
Year: 2013

REM rebound during CPAP titration as a predictor of chronic CPAP compliance
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


The effect of CPAP withdrawal on blood pressure in OSA: Data from three randomised-controlled trials
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014

OSAS patients can exhibit nocturnal IL-6 upregulation triggered by apnea related strenuous diaphragmatic contractions and oxygen desaturation. A case controlled prospective study
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014

LATE-BREAKING ABSTRACT: Zonisamide reduces obstructive sleep apnea: A randomized placebo-controlled study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015


Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018
Year: 2018



Tri-level ventilation versus CPAP treatment in treatment of complex sleep apnoea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015

CPAP treatment response in obstructive sleep apnea using the AERScore predictor
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015